Evidence map›Paper›PMID 30017584›Full record

ArticleMolecular cell2018

MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining.

Putzer J Hung, Britney Johnson, Bo-Ruei Chen, Andrea K Byrum, Andrea L Bredemeyer, William T Yewdell, Tanya E Johnson, Brian J Lee, Shruthi Deivasigamani, Issa Hindi and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. CRISPR-Cas9 screening reveals microproteins regulating adipocyte proliferation and lipid metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Nuclear VPS35 attenuates NHEJ repair by sequestering Ku protein.Molecular medicine (Cambridge, Mass.) · 2025
    Article
  10. Eukaryotic Microproteins.Annual review of biochemistry · 2025
    Review
  11. Article
  12. Article
  13. THE GID COMPLEX REGULATES DNA END PROCESSING DURING DNA DOUBLE-STRAND BREAK REPAIR BY NONHOMOLOGOUS END JOINING.Transactions of the American Clinical and Climatological Association · 2025
    Article
  14. Article
  15. Orientation Regulation of Class-switch Recombination in Human B Cells.Journal of immunology (Baltimore, Md. : 1950) · 2024
    Article
  16. Noncanonical microprotein regulation of immunity.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Review
  17. Review
  18. Article
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Putzer J HungDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Britney JohnsonDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Bo-Ruei ChenDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Andrea K ByrumDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Andrea L BredemeyerDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
William T YewdellImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Tanya E JohnsonThe Department of Molecular Biosciences and the Howard Hughes Medical Institute, The University of Texas at Austin, Austin, TX 78712, USA.
Brian J LeeInstitute for Cancer Genetics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Shruthi DeivasigamaniDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Issa HindiDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Parmeshwar AmatyaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Michael L GrossDepartment of Chemistry, Washington University, One Brookings Drive, St. Louis, MO 63130, USA.
Tanya T PaullThe Department of Molecular Biosciences and the Howard Hughes Medical Institute, The University of Texas at Austin, Austin, TX 78712, USA.
David J PisapiaDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Jayanta ChaudhuriImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
John J H PetriniMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Nima MosammaparastDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Gaya K AmarasingheDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Shan ZhaInstitute for Cancer Genetics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Jessica K TylerDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Barry P SleckmanDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: bas2022@med.cornell.edu.
Washington University in St. Louis · USCornell University · USMemorial Sloan Kettering Cancer Center · USCancer Genetics (United States) · USHoward Hughes Medical Institute · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Virology BSL4 CoreP01AI120943 · NIAID · WASHINGTON UNIVERSITY · PI Gaya K. Amarasinghe · 2016 to 2026
$30.2M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
ROLES OF MRELL AND RAD50 IN THE DNA DAMAGE RESPONSER01GM056888 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI PETRINI, JOHN HJ · 1998 to 2019
$8.6M
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENTR01AI047829 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2000 to 2021
$7.0M
ATM FUNCTION DURING V(D)J RECOMBINATIONR01AI074953 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2009 to 2023
$5.9M
The role of ATM in the suppression of lymphoid malignancyR01CA158073 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Shan Zha · 2011 to 2026
$5.7M
Regulation of the DNA damage response by the Mre11 complexR37GM059413 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI PETRINI, JOHN HJ · 2012 to 2020
$5.2M
Chromatin's Role in Repair of Radiation-induced Damage.R01CA095641 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI TYLER, JESSICA K · 2002 to 2023
$5.2M
The Mre11 complex: linking recombination to checkpointsR01GM059413 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI PETRINI, JOHN HJ · 1999 to 2011
$5.2M
Chromatin Assembly, Structure and FunctionR01GM064475 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI TYLER, JESSICA K · 2002 to 2019
$4.4M
MECHANISM AND REGULATION OF THE DNA ALKYLATION DAMAGE RESPONSER01CA193318 · NCI · WASHINGTON UNIVERSITY · PI MOSAMMAPARAST, NIMA · 2015 to 2024
$3.6M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA095641NCI NIH HHS R01 CA158073NCI NIH HHS R01 CA184187NCI NIH HHS R01 CA193318NCI NIH HHS R13 CA162528NIAID NIH HHS P01 AI120943NIAID NIH HHS R01 AI047829NIAID NIH HHS R01 AI074953NIGMS NIH HHS P41 GM103422NIGMS NIH HHS R01 GM056888NIGMS NIH HHS R01 GM059413NIGMS NIH HHS R01 GM064475NIGMS NIH HHS R24 GM136766NIGMS NIH HHS R37 GM059413
6 · The paper itself

Abstract

The modulator of retrovirus infection (MRI or CYREN) is a 30-kDa protein with a conserved N-terminal Ku-binding motif (KBM) and a C-terminal XLF-like motif (XLM). We show that MRI is intrinsically disordered and interacts with many DNA damage response (DDR) proteins, including the kinases ataxia telangiectasia mutated (ATM) and DNA-PKcs and the classical non-homologous end joining (cNHEJ) factors Ku70, Ku80, XRCC4, XLF, PAXX, and XRCC4. MRI forms large multimeric complexes that depend on its N and C termini and localizes to DNA double-strand breaks (DSBs), where it promotes the retention of DDR factors. Mice deficient in MRI and XLF exhibit embryonic lethality at a stage similar to those deficient in the core cNHEJ factors XRCC4 or DNA ligase IV. Moreover, MRI is required for cNHEJ-mediated DSB repair in XLF-deficient lymphocytes. We propose that MRI is an adaptor that, through multivalent interactions, increases the avidity of DDR factors to DSB-associated chromatin to promote cNHEJ.

Indexed as

DNA Breaks, Double-StrandedDNA End-Joining RepairAnimalsCell Cycle ProteinsChromatinDNA-Binding ProteinsDNA Ligase ATPDNA RepairDNA Repair EnzymesHumansKu AutoantigenMiceCell Cycle ProteinsChromatinDNA-Binding ProteinsDNA Ligase ATPDNA Repair EnzymesKu AutoantigenNHEJ1 protein, humanPAXX protein, humanXLF protein, mouseXRCC4 protein, humanadaptor proteinCYRENDNA double-strand break repairMRInon-homologous end joiningV(D)J recombination

Identifiers

PMID30017584
PMCPMC6083883
OpenAlexW2883643479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.